CEBPG and acute myeloid leukemia: By interrogating ChIP-Seq data of AML cell lines (Fig, 1a, tracks 1–6, K562 cell line also included) and non-AML hematopoietic cells (Fig. 1a, tracks 7–10), we found that the enhancer region of CEBPG in AML cell lines showed coincident H3K27ac signals that were not present in non-AML hematopoietic cells, suggesting a potential role in transcription regulation.